Who Owns CRISPR THERAPEUTICS AG NAMEN AKT (CRSP)? -- Institutional Holders (2026-06-30)

18 institutions reported holding $9.4M of CRISPR THERAPEUTICS AG NAMEN AKT (CRSP) in SEC 13F filings for 2026-06-30. Largest institutional holders: CONGRESS ASSET MANAGEMENT CO ($6.0M), Hennion & Walsh Asset Management, Inc. ($1.7M), BRAVE ASSET MANAGEMENT INC ($612,702), 180 WEALTH ADVISORS, LLC ($395,797), Quad-Cities Investment Group, LLC ($227,105). Source: SEC Form 13F.

RankInstitutionValueSharesChange
1CONGRESS ASSET MANAGEMENT CO$6.0M109,453Added
2Hennion & Walsh Asset Management, Inc.$1.7M30,485Added
3BRAVE ASSET MANAGEMENT INC$612,70211,234Trimmed
4180 WEALTH ADVISORS, LLC$395,7977,257Trimmed
5Quad-Cities Investment Group, LLC$227,1054,164New
6Valeo Financial Advisors, LLC$201,1983,689New
7HARBOR INVESTMENT ADVISORY, LLC$125,4422,300Trimmed
8THURSTON, SPRINGER, MILLER, HERD & TITAK, INC.$89,2711,637Added
9GAMMA Investing LLC$35,396649Added
10Versant Capital Management, Inc$25,361465Added
11BEACON INVESTMENT ADVISORY SERVICES, INC.$14,781271Hold
12CX Institutional$9,000174Hold
13CoreCap Advisors, LLC$5,39999Hold
14Dogwood Wealth Management LLC$4,36380Hold
15Kozak & Associates, Inc.$1,44626Hold
16Strategic Investment Solutions, Inc. /IL$54510Added
17MassMutual Private Wealth & Trust, FSB$4368Hold
18FNY Investment Advisers, LLC$010New

Source: SEC Form 13F filings · as of 2026-06-30